Effect | Increase |
Trial Design | Double blind |
Trial Length | 1-6 months |
Number of Subjects | 40 |
Sex | Both Genders |
Age Range | 45-64 |
In persons with type II diabetic nephropathy (declining kidney function associated with type II diabetes), curcumin at 22.1mg thrice a day (via turmeric) was able to exert anti-inflammatory effects (significant decrease in TGF-β, no significant influence on IL-8 or TNF-a) and decrease proteinuria (protein in the urine) over 2 months.